The University of Southampton
University of Southampton Institutional Repository

High-frequency oscillatory ventilation for the prevention of chronic lung disease of prematurity

High-frequency oscillatory ventilation for the prevention of chronic lung disease of prematurity
High-frequency oscillatory ventilation for the prevention of chronic lung disease of prematurity
BACKGROUND: There remains uncertainty concerning the safety and efficacy of high-frequency oscillatory ventilation as compared with those of conventional ventilation for the respiratory support of very preterm infants. We conducted a multicenter trial to determine whether early intervention with high-frequency oscillatory ventilation reduced mortality and the incidence of chronic lung disease among newborns with a gestational age of 28 weeks or less.
METHODS: We randomly assigned preterm infants with a gestational age of 23 to 28 weeks to either conventional ventilation or high-frequency oscillatory ventilation within one hour after birth. Randomization was stratified according to center and gestational age (23 to 25 weeks or 26 to 28 weeks).
RESULTS: A total of 400 infants were assigned to high-frequency oscillatory ventilation, and 397 were assigned to conventional ventilation. The composite primary outcome (death or chronic lung disease, diagnosed at 36 weeks of postmenstrual age) occurred in 66 percent of the infants assigned to receive high-frequency oscillatory ventilation and 68 percent of those in the conventional-ventilation group (relative risk in the group assigned to high-frequency oscillatory ventilation, 0.98; 95 percent confidence interval, 0.89 to 1.08). Similar proportions of infants died or had chronic lung disease in each gestational-age group. In both treatment groups treatment failure occurred in 10 percent of infants (relative risk in the group assigned to high-frequency oscillatory ventilation, 0.99; 95 percent confidence interval, 0.66 to 1.50). There were no significant differences between the groups in a range of other secondary outcome measures, including serious brain injury and air leak.
CONCLUSIONS: The results obtained with high-frequency oscillatory ventilation and conventional ventilation do not differ significantly in the early treatment of respiratory disease in very preterm infants. Assessment of long-term effects will require additional follow-up.
London, premature, adverse effects, controlled trial, prevention & control, therapy, health, infant, female, risk, high-frequency ventilation, equipment design, prematurity, etiology, secondary, efficacy, child, mortality, newborn, intracranial hemorrhages, incidence, prevention, survival analysis, methods, male, injuries, safety, research, physiopathology, lung, multicenter studies, treatment failure, controlled-trial, treatment, oxygen inhalation therapy, gestational age, trial, comparative study, respiratory distress syndrome, birth, humans, clinical-trial, bronchopulmonary dysplasia, research support, chronic lung disease, artificial, disease, brain, chronic, respiration
633-642
Johnson, Alice H.
ac48dc50-5da5-498d-89ed-aa8491422013
Peacock, Janet L.
1cb1242c-7606-4f8e-86d0-d3cd2ceff782
Greenough, Anne
5fb7521d-ae58-4a58-9a0b-deddcf1647c2
Marlow, Neil
0c6bd3b0-464b-4f04-8dd3-72517da5cbd7
Limb, Elizabeth S.
8ef66d6e-3265-40d5-94c4-90c38bd808f1
Marston, Louise
258cc87f-2cf7-49de-9498-fc659a5ffde7
Calvert, Sandra A.
57fee0d9-0583-4b75-99d4-58c72a3b2e2a
Johnson, Alice H.
ac48dc50-5da5-498d-89ed-aa8491422013
Peacock, Janet L.
1cb1242c-7606-4f8e-86d0-d3cd2ceff782
Greenough, Anne
5fb7521d-ae58-4a58-9a0b-deddcf1647c2
Marlow, Neil
0c6bd3b0-464b-4f04-8dd3-72517da5cbd7
Limb, Elizabeth S.
8ef66d6e-3265-40d5-94c4-90c38bd808f1
Marston, Louise
258cc87f-2cf7-49de-9498-fc659a5ffde7
Calvert, Sandra A.
57fee0d9-0583-4b75-99d4-58c72a3b2e2a

Johnson, Alice H., Peacock, Janet L., Greenough, Anne, Marlow, Neil, Limb, Elizabeth S., Marston, Louise and Calvert, Sandra A. (2002) High-frequency oscillatory ventilation for the prevention of chronic lung disease of prematurity. New England Journal of Medicine, 347 (9), 633-642.

Record type: Article

Abstract

BACKGROUND: There remains uncertainty concerning the safety and efficacy of high-frequency oscillatory ventilation as compared with those of conventional ventilation for the respiratory support of very preterm infants. We conducted a multicenter trial to determine whether early intervention with high-frequency oscillatory ventilation reduced mortality and the incidence of chronic lung disease among newborns with a gestational age of 28 weeks or less.
METHODS: We randomly assigned preterm infants with a gestational age of 23 to 28 weeks to either conventional ventilation or high-frequency oscillatory ventilation within one hour after birth. Randomization was stratified according to center and gestational age (23 to 25 weeks or 26 to 28 weeks).
RESULTS: A total of 400 infants were assigned to high-frequency oscillatory ventilation, and 397 were assigned to conventional ventilation. The composite primary outcome (death or chronic lung disease, diagnosed at 36 weeks of postmenstrual age) occurred in 66 percent of the infants assigned to receive high-frequency oscillatory ventilation and 68 percent of those in the conventional-ventilation group (relative risk in the group assigned to high-frequency oscillatory ventilation, 0.98; 95 percent confidence interval, 0.89 to 1.08). Similar proportions of infants died or had chronic lung disease in each gestational-age group. In both treatment groups treatment failure occurred in 10 percent of infants (relative risk in the group assigned to high-frequency oscillatory ventilation, 0.99; 95 percent confidence interval, 0.66 to 1.50). There were no significant differences between the groups in a range of other secondary outcome measures, including serious brain injury and air leak.
CONCLUSIONS: The results obtained with high-frequency oscillatory ventilation and conventional ventilation do not differ significantly in the early treatment of respiratory disease in very preterm infants. Assessment of long-term effects will require additional follow-up.

This record has no associated files available for download.

More information

Published date: 2002
Keywords: London, premature, adverse effects, controlled trial, prevention & control, therapy, health, infant, female, risk, high-frequency ventilation, equipment design, prematurity, etiology, secondary, efficacy, child, mortality, newborn, intracranial hemorrhages, incidence, prevention, survival analysis, methods, male, injuries, safety, research, physiopathology, lung, multicenter studies, treatment failure, controlled-trial, treatment, oxygen inhalation therapy, gestational age, trial, comparative study, respiratory distress syndrome, birth, humans, clinical-trial, bronchopulmonary dysplasia, research support, chronic lung disease, artificial, disease, brain, chronic, respiration

Identifiers

Local EPrints ID: 61830
URI: http://eprints.soton.ac.uk/id/eprint/61830
PURE UUID: cccbf43f-7e17-43b2-b3f8-6d1205d18655

Catalogue record

Date deposited: 09 Sep 2008
Last modified: 08 Jan 2022 01:13

Export record

Contributors

Author: Alice H. Johnson
Author: Janet L. Peacock
Author: Anne Greenough
Author: Neil Marlow
Author: Elizabeth S. Limb
Author: Louise Marston
Author: Sandra A. Calvert

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×